SAB Biotherapeutics SABS SEC Filings

NASDAQ SABS
$2.91 +0.03 (+1.04%)
As of: Oct 21, 2026 · 11:36 AM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing SAB Biotherapeutics, Inc. (SABS) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
18-KCurrent Report0001193125-26-419769Oct 13, 2026 4:36 PM
24Insider Transaction0001193125-26-395552Sep 18, 2026 8:15 PM
3424B3Prospectus0001193125-26-361180Aug 21, 2026 8:30 PM
410-QQuarterly & Annual Report0001193125-26-336783Aug 6, 2026 11:56 AM
58-KCurrent Report0001193125-26-296936Jul 7, 2026 8:15 AM
64Insider Transaction0001193125-26-285722Jun 26, 2026 9:20 PM
78-KCurrent Report0001193125-26-275976Jun 18, 2026 8:35 PM
8SCHEDULE 13GBeneficial Ownership Report0001193125-26-226560May 15, 2026 8:00 PM
9SCHEDULE 13GBeneficial Ownership Report0001727492-26-000011May 15, 2026 3:17 PM
10SCHEDULE 13GBeneficial Ownership Report0001193125-26-225169May 15, 2026 10:28 AM
1110-QQuarterly & Annual Report0001193125-26-218195May 12, 2026 7:35 AM
128-KCurrent Report0001193125-26-204125May 4, 2026 8:35 PM
13SCHEDULE 13GBeneficial Ownership Report0001104659-26-054220May 1, 2026 8:57 PM
14DEF 14AOthers0001193125-26-197607Apr 30, 2026 4:45 PM
158-KCurrent Report0001193125-26-168569Apr 22, 2026 8:13 AM
16S-8Prospectus0001193125-26-134733Mar 31, 2026 5:35 PM
174Insider Transaction0001193125-26-124231Mar 25, 2026 4:35 PM
184Insider Transaction0001193125-26-124231Mar 25, 2026 4:35 PM
194Insider Transaction0001193125-26-124231Mar 25, 2026 4:35 PM
20SCHEDULE 13DBeneficial Ownership Report0001346824-26-000079Mar 23, 2026 4:25 PM
218-KCurrent Report0001193125-26-114730Mar 19, 2026 8:28 PM
22424B5Prospectus0001193125-26-114728Mar 19, 2026 8:26 PM
23424B5Prospectus0001193125-26-110666Mar 17, 2026 4:00 PM
24SCHEDULE 13DBeneficial Ownership Report0001346824-26-000072Mar 11, 2026 4:43 PM
258-KCurrent Report0001193125-26-099376Mar 10, 2026 7:35 AM
2610-KQuarterly & Annual Report0001833214-26-000003Mar 9, 2026 5:10 PM
27SCHEDULE 13GBeneficial Ownership Report0000921895-26-000472Feb 17, 2026 4:23 PM
28SCHEDULE 13GBeneficial Ownership Report0001493215-26-000048Feb 17, 2026 8:47 AM
294Insider Transaction0001193125-26-039577Feb 5, 2026 4:55 PM
304Insider Transaction0001193125-26-039577Feb 5, 2026 4:55 PM
314Insider Transaction0001193125-26-039577Feb 5, 2026 4:55 PM
324Insider Transaction0001193125-26-039564Feb 5, 2026 4:50 PM
334Insider Transaction0001193125-26-039564Feb 5, 2026 4:50 PM
344Insider Transaction0001193125-26-039564Feb 5, 2026 4:50 PM
354Insider Transaction0001193125-26-039537Feb 5, 2026 4:45 PM
364Insider Transaction0001193125-26-039537Feb 5, 2026 4:45 PM
374Insider Transaction0001193125-26-039537Feb 5, 2026 4:45 PM
384Insider Transaction0001193125-26-039524Feb 5, 2026 4:40 PM
394Insider Transaction0001193125-26-039508Feb 5, 2026 4:35 PM
404Insider Transaction0001193125-26-039508Feb 5, 2026 4:35 PM
414Insider Transaction0001193125-26-039508Feb 5, 2026 4:35 PM
42SCHEDULE 13GBeneficial Ownership Report0001193125-26-019535Jan 22, 2026 4:34 PM
438-KCurrent Report0001193125-26-010515Jan 12, 2026 4:47 PM
44EFFECTOthers9999999995-26-000101Jan 7, 2026 12:15 AM
454Insider Transaction0001193125-26-006435Jan 7, 2026 4:41 PM
464Insider Transaction0001193125-26-006427Jan 7, 2026 4:40 PM
474Insider Transaction0001193125-26-006427Jan 7, 2026 4:40 PM
484Insider Transaction0001193125-26-006427Jan 7, 2026 4:40 PM
493Insider Transaction0001193125-26-006411Jan 7, 2026 4:36 PM
503Insider Transaction0001193125-26-006407Jan 7, 2026 4:35 PM
...

SAB Biotherapeutics, Inc. SEC Filings API

Pull SAB Biotherapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=SABS&formtype=10-K,10-Q&api_key=YOUR_API_KEY